Calcium-phosphorus therapy for heart valve disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a treatment to lower high calcium and phosphorus levels in your blood, which may slow down calcium buildup in heart valves. It may help people with kidney problems who have valve disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older.
- You have heart valve disease with calcium buildup, as shown by an ultrasound or other tests.
- Your kidney function (filtration rate) is below 60 mL/min.
- Your blood phosphorus level is higher than 4.5 mg/dL (1.45 mmol/L).
- You do not have other types of valve disease, such as rheumatic or congenital valve disease.
- You are not scheduled for dialysis within the next 6 months and have no planned heart surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called a PCSK9 inhibitor, which lowers cholesterol. It may slow down the buildup of calcium in the aortic valve, which can narrow the valve and make it harder for blood to flow. The drug is given as an injection, and you would receive it for 24 months.
This study follows older adults in China who have heart valve problems to better understand how these conditions affect people over time. If you join, your health information and follow-up visits will help doctors learn more about valve disease in the elderly and improve future care.
This trial tests a new drug, JMKX003002, to lower high phosphorus levels in people with end-stage kidney disease who are on hemodialysis. If you have trouble controlling your phosphorus, this treatment might help.
This trial tests if the drug vericiguat can slow down the buildup of calcium in the aortic valve, which causes it to narrow and stiffen. If you have mild-to-moderate aortic valve stenosis and meet the other criteria, this study may help protect your valve from getting worse.
This study looks at how eating different amounts of phosphorus affects your bones and blood calcium and phosphorus. It may help find better dietary recommendations for people with moderate chronic kidney disease.
This study tests whether a new medicine called TS-172 can help lower phosphorus levels in patients on peritoneal dialysis (a type of kidney treatment). High phosphorus can cause bone problems and other complications, so the trial aims to see if this drug works better than current treatments.
Hear when a new Degenerative Heart Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.